Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Sep 6;10(9):1249.
doi: 10.3390/nu10091249.

Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation

Affiliations
Review

Effects of Vegetable Proteins on Hypercholesterolemia and Gut Microbiota Modulation

Marco Busnelli et al. Nutrients. .

Abstract

Risk assessment tools, i.e., validated risk prediction algorithms, to estimate the patient's 10-year risk of developing cardiovascular disease (CVD) should be used to identify high-risk people for primary prevention. Current evidence confirms that appropriate monitoring and control of risk factors either reduces the likelihood of CVD or slows down its progression. It is thus crucial that all health professionals make appropriate use of all the available intervention strategies to control risk factors: from dietary improvement and adequate physical activity to the use of functional foods, food supplements, and drugs. The gut microbiota, which encompasses 1 × 1014 resident microorganisms, has been recently recognized as a contributing factor in the development of human disease. This review examines the effect of both some vegetable food components belong to the "protein food group" and the underexploited protein-rich hempseed on cholesterolemia and gut microbiota composition.

Keywords: LDL-receptor; PCSK9; cholesterol; functional food; hempseed; lupins; microbiota; peas; protein food group; soybeans.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Treatment effect linked to cholesterol levels on the potential age of clinical cardiovascular event appearance. Treated means a multifactor intervention, i.e., dietary and lifestyle modifications plus the consumption of functional foods plus the use of drugs.
Figure 2
Figure 2
Impact of the dietary intake on gut microbiota and on human disease. Athero CVD (cardiovascular disease) means Atherosclerotic cardiovascular disease.

References

    1. Dorresteijn J.A., Kaasenbrood L., Cook N.R., van Kruijsdijk R.C., van der Graaf Y., Visseren F.L., Ridker P.M. How to translate clinical trial results into gain in healthy life expectancy for individual patients. BMJ. 2016;352:i1548. doi: 10.1136/bmj.i1548. - DOI - PubMed
    1. Hippisley-Cox J., Coupland C., Robson J., Brindle P. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: Cohort study using QResearch database. BMJ. 2010;341:c6624. doi: 10.1136/bmj.c6624. - DOI - PMC - PubMed
    1. Piepoli M.F., Hoes A.W., Agewall S., Albus C., Brotons C., Catapano A.L., Cooney M.T., Corra U., Cosyns B., Deaton C., et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) Eur. Heart J. 2016;37:2315–2381. doi: 10.1093/eurheartj/ehw106. - DOI - PMC - PubMed
    1. Goff D.C., Jr., Lloyd-Jones D.M., Bennett G., Coady S., D’Agostino R.B., Sr., Gibbons R., Greenland P., Lackland D.T., Levy D., O’Donnell C.J., et al. American College of Cardiology/American Heart Association Task Force on Practice, G., 2013 ACC/AHA guideline on the assessment of cardiovascular risk: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. JACC. 2014;63:2935–2959. doi: 10.1016/j.jacc.2013.11.005. - DOI - PMC - PubMed
    1. Jaspers N.E.M., Visseren F.L.J., Numans M.E., Smulders Y.M., van Loenen Martinet F.A., van der Graaf Y., Dorresteijn J.A.N. Variation in minimum desired cardiovascular disease-free longevity benefit from statin and antihypertensive medications: A cross-sectional study of patient and primary care physician perspectives. BMJ Open. 2018;8:e021309. doi: 10.1136/bmjopen-2017-021309. - DOI - PMC - PubMed

MeSH terms